SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000892569-97-000969
Filing Date
1997-04-08
Accepted
1997-04-08 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL MATERIALS TO DEFINITIVE PROXY DEFA14A 61215
  Complete submission text file 0000892569-97-000969.txt   62656
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 6194526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24274 | Film No.: 97576392
SIC: 2836 Biological Products, (No Diagnostic Substances)